Companies with a Future performance score of at least 3, ordered by Future performance score.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
GOLDR	NOK 7.88	3.4%	n/a	NOK 451.7m	n/a	20.7	86.0%	n/a	Materials
KEBNI B	SEK 1.09	2.1%	-48.2%	SEK 299.8m	SEK 1.25	3.0	105.2%	n/a	Tech
VALU	ج.م11.00	-1.3%	35.5%	ج.م23.2b	ج.م16.00	25.5	47.1%	n/a	Diversified Financials
GH	US$163.34	-1.1%	179.2%	US$21.5b	US$194.29	18.5	64.6%	n/a	Healthcare
AXSM	US$218.20	1.6%	86.5%	US$11.3b	US$285.42	14.7	61.1%	n/a	Pharmaceuticals & Biotech
AMAP	CA$1.12	0.9%	n/a	CA$383.7m	CA$2.00	7.0	44.5%	n/a	Materials
FWRY	ج.م19.00	0.6%	39.1%	ج.م64.7b	ج.م22.45	24.3	27.3%	n/a	Diversified Financials
CDR	zł256.50	-3.7%	1.8%	zł25.6b	zł236.05	49.6	39.6%	0.4%	Media
COXG	€11.35	4.1%	8.1%	€962.8m	€14.75	0.6	44.8%	n/a	Utilities
WAYS	SEK 39.20	1.8%	-1.3%	SEK 343.8m	SEK 58.00	208.6	78.5%	0%	Tech
LPK	€13.70	-16.7%	68.9%	€335.0m	€22.75	3.4	116.6%	0%	Tech
MDGL	US$540.16	0.7%	37.9%	US$12.1b	US$678.06	9.7	63.7%	n/a	Pharmaceuticals & Biotech
AAZ	UK£3.93	-4.8%	138.6%	UK£448.8m	UK£5.68	34.5	25.9%	0.7%	Materials
AGP	€7.17	-0.1%	-10.6%	€130.7m	€8.57	26.3	39.1%	n/a	Capital Goods
VLA	€2.90	17.9%	-40.9%	€550.0m	€6.19	3.8	71.7%	n/a	Pharmaceuticals & Biotech
ESTA	US$75.36	-0.3%	92.8%	US$2.2b	US$102.44	9.1	112.2%	n/a	Healthcare
MVW	NOK 8.00	30.1%	-10.1%	NOK 282.4m	NOK 7.00	10.1	68.9%	n/a	Materials
TVTX	US$65.96	6.1%	267.1%	US$6.0b	US$74.14	10.5	53.1%	n/a	Pharmaceuticals & Biotech
INR	US$14.43	4.9%	4.9%	US$892.4m	US$22.63	5.3	58.2%	n/a	Energy
TMGH	ج.م97.00	-1.4%	76.2%	ج.م199.9b	ج.م141.90	12.9	35.9%	0.3%	Real Estate Management and Development
MOD	US$195.14	-2.2%	44.6%	US$10.7b	US$310.29	71.9	51.3%	n/a	Capital Goods
SAUD3	R$13.92	1.5%	7.6%	R$40.7b	R$17.69	38.6	31.9%	5.8%	Healthcare
RHM	€1,178.80	0.9%	-24.3%	€55.0b	€1,679.38	45.5	30.5%	1.0%	Capital Goods
CRDO	US$234.82	-12.4%	121.5%	US$45.9b	US$283.23	92.7	27.7%	n/a	Semiconductors

High Growth Potential Companies